ArticleCancer nanotechnology2021

Radiolabeling and PET-MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer.

Mariane Le Fur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.